| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/06/2011 | WO2011002642A1 Sensor films, methods for making and methods for monitoring water-soluble polymer concentrations |
| 01/06/2011 | WO2011002310A1 Printing of fsl constructs |
| 01/06/2011 | WO2011002292A1 Novel diagnostic method for diagnosing depression |
| 01/06/2011 | WO2011002251A2 Marker for predicting fertility |
| 01/06/2011 | WO2011002157A2 Marker for diagnosing papillary thyroid carcinoma containing 3-indoleacetonitrile as an active ingredient |
| 01/06/2011 | WO2011002152A2 Sensor used together with a detector to measure biomaterial, and apparatus using same |
| 01/06/2011 | WO2011002029A1 Method for determination of presence of cancer cell, and method for determination of prognosis of cancer patient |
| 01/06/2011 | WO2011002024A1 Method for determining presence or absence of epithelial cancer-origin cell in biological sample, and molecular marker and kit therefor |
| 01/06/2011 | WO2011001999A1 Immunological measurement reagent for use in measurement of kl-6 |
| 01/06/2011 | WO2011001885A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit |
| 01/06/2011 | WO2011001681A1 Blood analyzer and blood analyzing method |
| 01/06/2011 | WO2011001597A1 Substrate for immobilizing biological substance and method for producing same |
| 01/06/2011 | WO2011001530A1 Instrument for analyzing body fluid components |
| 01/06/2011 | WO2011001432A1 Novel antibodies and their uses in therapeutic and diagnostic methods |
| 01/06/2011 | WO2011001337A1 Magnetic sensor device, method of operating such a device and sample |
| 01/06/2011 | WO2011001269A2 System and method for drilling using drilling fluids |
| 01/06/2011 | WO2011001191A1 Method for the detection of organ or tissue injury |
| 01/06/2011 | WO2011001156A1 Aroma training apparatus and method |
| 01/06/2011 | WO2011001138A1 Vibrating microplate biosensing for characterising properties of behaviour of biological cells |
| 01/06/2011 | WO2011001029A1 Detection of igfbp-4 fragments as a diagnostic method |
| 01/06/2011 | WO2011000991A1 Method for identifying peptides and proteins according to mass spectrometry data |
| 01/06/2011 | WO2011000959A1 Point-of-care test system and method for applying a sample |
| 01/06/2011 | WO2011000944A1 Method for storing and tracing of manual blood typing analyses |
| 01/06/2011 | WO2011000938A1 Method and markers for diagnosing acute renal failure |
| 01/06/2011 | WO2011000894A1 Method of detecting tumour cells by fluorescence signals |
| 01/06/2011 | WO2011000891A1 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta |
| 01/06/2011 | WO2011000874A1 Methods for predicting cardiovascular mortality risk |
| 01/06/2011 | WO2011000860A2 Targets for retrovirus associated diseases |
| 01/06/2011 | WO2011000833A1 Gene signature for replicative senescence in cell cultures |
| 01/06/2011 | WO2011000805A1 Biomarkers of oocyte competency and method of use |
| 01/06/2011 | WO2011000773A1 Testing efficacy for celiac disease |
| 01/06/2011 | WO2011000584A1 Sensor element for determining a property of a gas |
| 01/06/2011 | WO2011000573A1 Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms |
| 01/06/2011 | WO2011000572A1 Method and device for detecting long-term biological effects in cells |
| 01/06/2011 | WO2011000486A2 Method for obtaining electrical energy from the kinetic energy of waves |
| 01/06/2011 | WO2011000388A1 Methods of predicting clinical outcome in malignant melanoma |
| 01/06/2011 | WO2011000190A1 Long-term portable kit for rapid testing of sulfhydryl in body fluid |
| 01/06/2011 | WO2011000047A1 Quantitative and self-calibrating chemical analysis using paper-based microfluidic systems |
| 01/06/2011 | WO2011000032A1 Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity |
| 01/06/2011 | WO2011000026A1 Terpene synthases from santalum |
| 01/06/2011 | WO2010130839A4 Cybp as a marker of lung cancer |
| 01/06/2011 | WO2010129656A8 Method of oligonucleotide labeling using cycloaddition reaction |
| 01/06/2011 | WO2010128232A3 Method for diagnosing propionibacterium acnes infections |
| 01/06/2011 | WO2010128163A3 Small molecule inhibitors of influenza a and b virus and respiratory syncytial virus replication |
| 01/06/2011 | WO2010123406A3 Multi-functional nanomaterial based on modified archaeal halobacterium salinarum flagella (embodiments) and a method for producing same |
| 01/06/2011 | WO2010111691A9 Conjugates of biomolecules to nanoparticles |
| 01/06/2011 | WO2010104761A3 Anti-cd40 antibodies and uses thereof |
| 01/06/2011 | WO2010101931A3 Detection system and method for high sensitivity fluorescent assays |
| 01/06/2011 | WO2010101926A3 Microfluidic system for high-throughput, droplet-based single molecule analysis with low reagent consumption |
| 01/06/2011 | WO2010099477A3 Polypeptide structural motifs associated with cell signaling activity |
| 01/06/2011 | WO2010099455A3 Glass substrate orientation inspection methods and systems for photo voltaics production |
| 01/06/2011 | WO2010099432A3 Recognition of cyp2e1 epitopes |
| 01/06/2011 | WO2010098613A3 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer |
| 01/06/2011 | WO2010098502A9 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases |
| 01/06/2011 | WO2010096674A3 A+ biomarker assays |
| 01/06/2011 | WO2010096604A3 Uses of cancer-targeting peptides in cancer diagnosis |
| 01/06/2011 | WO2010096414A3 Metal-enhanced bioluminescence: an approach for monitoring biological bioluminescent processes |
| 01/06/2011 | WO2010096154A3 Compositions and methods for diagnosis and prognosis of colorectal cancer |
| 01/06/2011 | WO2010093939A3 Predicting and treating prostate cancer |
| 01/06/2011 | WO2010090758A3 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 01/06/2011 | WO2010090471A9 Novel diagnostic marker for type 1 diabetes mellitus |
| 01/06/2011 | WO2010060102A3 Prediction and prevention of preeclampsia |
| 01/06/2011 | WO2009007849A3 Il-23 receptor antagonists and uses thereof |
| 01/06/2011 | US20110004966 Dry blending aid |
| 01/06/2011 | US20110004960 Methods and Compositions for Increasing the Nitrogen Storage Capacity of a Plant |
| 01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 01/06/2011 | US20110004947 Compositions and methods for osteogenic gene therapy |
| 01/06/2011 | US20110004415 Digital cell |
| 01/06/2011 | US20110004414 Method for Predicting Respiratory Toxicity of Compounds |
| 01/06/2011 | US20110004413 Method and system for calling variations in a sample polynucleotide sequence with respect to a reference polynucleotide sequence |
| 01/06/2011 | US20110004189 System and method for providing optimal concentrations for medication infusions |
| 01/06/2011 | US20110003880 Compositions and methods for inhibiting optic nerve damage |
| 01/06/2011 | US20110003854 Breast cancer treatment and treatment prediction |
| 01/06/2011 | US20110003842 Marker for determination of sensitivity to anti-cancer agent |
| 01/06/2011 | US20110003813 Substituted biaryl piperazinyl-pyridine analogues |
| 01/06/2011 | US20110003734 Proteins and polynucleotides of vibrio cholerae |
| 01/06/2011 | US20110003716 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 01/06/2011 | US20110003715 Methods for detection and quantification of analytes in complex mixtures |
| 01/06/2011 | US20110003711 Cell lines expressing gaba receptor and methods using them |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110003709 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 01/06/2011 | US20110003708 Biomarkers for the prediction of renal injury |
| 01/06/2011 | US20110003707 Highly Sensitive Biomarker Panels |
| 01/06/2011 | US20110003706 Proliferation markers in clinical practice and their use for breast cancer prognosis or diagnosis |
| 01/06/2011 | US20110003401 Partial Derivatization of Particles |
| 01/06/2011 | US20110003400 Methods and systems for ground and surface water sampling and analysis |
| 01/06/2011 | US20110003399 Tumor Necrosis Factor-Gamma |
| 01/06/2011 | US20110003398 Assay device comprising serial reaction zones |
| 01/06/2011 | US20110003396 Explosives detection markers |
| 01/06/2011 | US20110003395 Specific analysis of analytes using reagent compounds, labeling strategies, and mass spectrometry workflow |
| 01/06/2011 | US20110003394 Encoded microparticles |
| 01/06/2011 | US20110003393 Systems and methods for studying influenza |
| 01/06/2011 | US20110003392 System and Method for Magnetically Concentrating and Detecting Biomarkers |
| 01/06/2011 | US20110003391 Sensor films, methods for making and methods for monitoring water-soluble polymer concentrations |
| 01/06/2011 | US20110003383 Antibodies to ht5gj57 |
| 01/06/2011 | US20110003372 Microfluidic gradient devices |
| 01/06/2011 | US20110003371 Diagnostic devices |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003335 Methods for prognosing the status of tumor patients |
| 01/06/2011 | US20110003321 Monitoring of Intercellular Mitochondorial Polarization |